Dimensional Fund Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Hold |
36,636
| – | – | ﹤0.01% | 2996 |
|
|
2025
Q1 | $374K | Sell |
36,636
-118,527
| -76% | -$1.21M | ﹤0.01% | 3036 |
|
|
2024
Q4 | $2.46M | Buy |
155,163
+2,727
| +2% | +$43.2K | ﹤0.01% | 2736 |
|
|
2024
Q3 | $8.85M | Sell |
152,436
-9,279
| -6% | -$539K | ﹤0.01% | 2352 |
|
|
2024
Q2 | $7.39M | Sell |
161,715
-3,691
| -2% | -$169K | ﹤0.01% | 2370 |
|
|
2024
Q1 | $10.9M | Sell |
165,406
-5,446
| -3% | -$361K | ﹤0.01% | 2270 |
|
|
2023
Q4 | $6.79M | Sell |
170,852
-425
| -0.2% | -$16.9K | ﹤0.01% | 2468 |
|
|
2023
Q3 | $5.46M | Buy |
171,277
+112,511
| +191% | +$3.59M | ﹤0.01% | 2503 |
|
|
2023
Q2 | $2.36M | Buy |
+58,766
| New | +$2.36M | ﹤0.01% | 2732 |
|